Bu e-kitob haqida
- Discusses where drugs and devices work, where they fail, and when they need to work with each other
- Reviews interactions between human bodies and the drug-device combination products the measurements of these interactions
- Covers how a drug-device combination product is developed, tested, and regulated
- Includes case studies of steroid releasing leads, AOA treated tissue heart valves, intrathecal drug delivery pumps, infuse bone grafts, drug eluting stents, and antimicrobial meshes
Muallif haqida
SuPing Lyu, PhD, joined, is a Principal Scientist at Medtronic, Inc., and his research focuses?on drug-device combination products, biomaterials, and biomaterial-biological interactions. He is a visiting professor of the Minnesota Center for Industrial Mathematics, School of Mathematics at University of Minnesota?and has?been a guest lecturer of biomaterials for the?university since 2006. In addition to authoring over 25 peer-reviewed papers, Dr. Lyu?served as an associate editor for the IEEE/EMBC 2009 conference.
Ronald A. Siegel, ScD, is Professor of Pharmaceutics and Biomedical Engineering at the University of Minnesota.?He is also Program Director of the Biomaterials and Pharmaceutical Materials program of Industrial Partners for Research in Interfacial and Materials Engineering.?Professor Siegel has published over 100 papers primarily on hydrogels, drug delivery devices, microsensors, and mathematical modelling of transport. He has received several research and best paper awards from both CRS and AAPS.
